Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein
- PMID: 36008493
- PMCID: PMC9411612
- DOI: 10.1038/s41467-022-32687-1
Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein
Abstract
Alpha-synuclein (αSyn) is a protein involved in neurodegenerative disorders including Parkinson's disease. Amyloid formation of αSyn can be modulated by the 'P1 region' (residues 36-42). Here, mutational studies of P1 reveal that Y39A and S42A extend the lag-phase of αSyn amyloid formation in vitro and rescue amyloid-associated cytotoxicity in C. elegans. Additionally, L38I αSyn forms amyloid fibrils more rapidly than WT, L38A has no effect, but L38M does not form amyloid fibrils in vitro and protects from proteotoxicity. Swapping the sequence of the two residues that differ in the P1 region of the paralogue γSyn to those of αSyn did not enhance fibril formation for γSyn. Peptide binding experiments using NMR showed that P1 synergises with residues in the NAC and C-terminal regions to initiate aggregation. The remarkable specificity of the interactions that control αSyn amyloid formation, identifies this region as a potential target for therapeutics, despite their weak and transient nature.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
Residues 2 to 7 of α-synuclein regulate amyloid formation via lipid-dependent and lipid-independent pathways.Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2315006121. doi: 10.1073/pnas.2315006121. Epub 2024 Aug 12. Proc Natl Acad Sci U S A. 2024. PMID: 39133842 Free PMC article.
-
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid.Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2309700120. doi: 10.1073/pnas.2309700120. Epub 2024 Jan 3. Proc Natl Acad Sci U S A. 2024. PMID: 38170745 Free PMC article.
-
A short motif in the N-terminal region of α-synuclein is critical for both aggregation and function.Nat Struct Mol Biol. 2020 Mar;27(3):249-259. doi: 10.1038/s41594-020-0384-x. Epub 2020 Mar 9. Nat Struct Mol Biol. 2020. PMID: 32157247 Free PMC article.
-
The emerging role of α-synuclein truncation in aggregation and disease.J Biol Chem. 2020 Jul 24;295(30):10224-10244. doi: 10.1074/jbc.REV120.011743. Epub 2020 May 18. J Biol Chem. 2020. PMID: 32424039 Free PMC article. Review.
-
Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.J Parkinsons Dis. 2020;10(3):819-830. doi: 10.3233/JPD-202085. J Parkinsons Dis. 2020. PMID: 32538869 Free PMC article. Review.
Cited by
-
Residues 2 to 7 of α-synuclein regulate amyloid formation via lipid-dependent and lipid-independent pathways.Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2315006121. doi: 10.1073/pnas.2315006121. Epub 2024 Aug 12. Proc Natl Acad Sci U S A. 2024. PMID: 39133842 Free PMC article.
-
Protein quality control: from molecular mechanisms to therapeutic intervention-EMBO workshop, May 21-26 2023, Srebreno, Croatia.Cell Stress Chaperones. 2023 Nov;28(6):631-640. doi: 10.1007/s12192-023-01383-4. Epub 2023 Sep 20. Cell Stress Chaperones. 2023. PMID: 37731161 Free PMC article. Review.
-
Role of conformational dynamics in pathogenic protein aggregation.Curr Opin Chem Biol. 2023 Apr;73:102280. doi: 10.1016/j.cbpa.2023.102280. Epub 2023 Mar 4. Curr Opin Chem Biol. 2023. PMID: 36878172 Free PMC article. Review.
-
Mechanistic Insights into Polyphenols' Aggregation Inhibition of α-Synuclein and Related Peptides.ACS Chem Neurosci. 2023 May 17;14(10):1905-1920. doi: 10.1021/acschemneuro.3c00162. Epub 2023 Apr 26. ACS Chem Neurosci. 2023. PMID: 37125909 Free PMC article.
-
Interplay of α-synuclein with Lipid Membranes: Cooperative Adsorption, Membrane Remodeling and Coaggregation.JACS Au. 2024 Mar 19;4(4):1250-1262. doi: 10.1021/jacsau.3c00579. eCollection 2024 Apr 22. JACS Au. 2024. PMID: 38665673 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- 101497/Z/13/Z/WT_/Wellcome Trust/United Kingdom
- BB/M011151/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BB/E012558/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- 094232 /WT_/Wellcome Trust/United Kingdom
- 204963/WT_/Wellcome Trust/United Kingdom
- 104918MA/WT_/Wellcome Trust/United Kingdom
- 215062/Z/18/Z/WT_/Wellcome Trust/United Kingdom
- MR/N013840/1/MRC_/Medical Research Council/United Kingdom
- NC/P001203/1/NC3RS_/National Centre for the Replacement, Refinement and Reduction of Animals in Research/United Kingdom
- 204963/Z/16/Z/WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Medical